Levetiracetam in the treatment of neonatal seizures: A pilot study

Seizure

Volumn 19, Issue 3, 2010, Pages 185-189

  Fürwentsches, Alexandra ^a   Bussmann, Cornelia ^a   Ramantani, Georgia ^a,b   Ebinger, Friedrich ^a   Philippi, Heike ^a   Pöschl, Johannes ^a   Schubert, Susanne ^a   Rating, Dietz ^a   Bast, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Epilepsy; Levetiracetam; Neonatal seizures

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; PHENOBARBITAL; SULTIAME;

ADD ON THERAPY; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL DECISION MAKING; MONOTHERAPY; NEWBORN; NEWBORN DISEASE; NEWBORN SEIZURE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEDATION; SEIZURE; SIDE EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PILOT PROJECTS; PIRACETAM; SEIZURES; TREATMENT OUTCOME;

EID: 77549083859     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.01.003     Document Type: Article

References (30)

1. Ronen G.M., Penney S., and Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. The Journal of Pediatrics 134 1 (1999) 71-75
2. Rennie J.M., and Boylan G.B. Neonatal seizures and their treatment. Current Opinion in Neurology 16 2 (2003) 177-181
3. Bittigau P., Sifringer M., and Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Annals of the New York Academy of Sciences 993 (2003) 103-114
4. Camfield C.S., Chaplin S., Doyle A.B., Shapiro S.H., Cummings C., and Camfield P.R. Side effects of phenobarbital in toddlers. The Journal of Pediatrics 95 (1979) 361-365
5. Glauser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J., et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 11 (2006) 1654-1660
6. Angehagen M., Margineanu D.G., Ben-Menachem E., Rönnbäck L., Hansson E., and Klitgaard H. Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons. Neuroreport 14 3 (2003) 471-475
7. Lukyanetz E.A., Shkryl V.M., and Kostyuk P.G. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43 1 (2002) 9-18
8. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proceedings of the National Academy of Sciences of the United States of America 101 26 (2004) 9861-9866
9. Rigo J.M., Hans G., Nguyen L., Rocher V., Belachew S., Malgrange B., et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. British Journal of Pharmacology 136 5 (2002) 659-672
10. Glauser T.A., Mitchell W.G., Weinstock A., Bebin M., Chen D., Coupez R., et al. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 48 6 (2007) 1117-1122
11. Radtke R.A. Pharmacokinetics of levetiracetam. Epilepsia 42 Suppl 4 (2001) 24-27
12. Privitera M. Efficacy of levetiracetam: a review of three pivotal clinical trials. Epilepsia 42 Suppl 4 (2001) 31-35
13. Opp J., Tuxhorn I., May T., Kluger G., Wiemer-Kruel A., Kurlemann G., et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 14 7 (2005) 476-484
14. Manthey D., Asimiadou S., Stefovska V., Kaindl A.M., Fassbender J., Ikonomidou C., et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Experimental Neurology 193 2 (2005) 497-503
15. Hanon E., and Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10 4 (2001) 287-293
16. Löscher W., Hönack D., and Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics 284 2 (1998) 474-479
17. Marini H., Costa C., Passaniti M., Esposito M., Campo G.M., Ientile R., et al. Levetiracetam protects against kainic acid-induced toxicity. Life Sciences 74 10 (2004) 1253-1264
18. Trollmann R., Schneider J., Keller S., Strasser K., Wenzel D., Rascher W., et al. HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam. Brain Research 1199 (2008) 27-36
19. Grosso S., Cordelli D.M., Franzoni E., Coppola G., Capovilla G., Zamponi N., et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 16 4 (2007) 345-350
20. Grosso S., Franzoni E., Coppola G., Iannetti P., Verrotti A., Cordelli D.M., et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14 4 (2005) 248-253
21. Perry M.S., and Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia 48 6 (2007) 1123-1127
22. Mikati M.A., El Banna D., Sinno D., and Mroueh S. Response of infantile spasms to levetiracetam. Neurology 70 7 (2008) 574-575
23. Striano P., Coppola A., Pezzella M., Ciampa C., Specchio N., Ragona F., et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69 3 (2007) 250-254
24. Goraya J.S., Khurana D.S., Valencia I., Melvin J.J., Cruz M., Legido A., et al. Intravenous levetiracetam in children with epilepsy. Pediatric Neurology 38 3 (2008) 177-180
25. Shoemaker M.T., and Rotenberg J.S. Levetiracetam for the treatment of neonatal seizures. Journal of Child Neurology 22 1 (2007) 95-98
26. Mizrahi E.M., and Kellaway P. Characterization and classification of neonatal seizures. Neurology 37 12 (1987) 1837-1844
27. Painter M.J., Scher M.S., Stein A.D., Armatti S., Wang Z., Gardiner J.C., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. The New England Journal of Medicine 341 7 (1999) 485-489
28. Murray D.M., Boylan G.B., Ali I., Ryan C.A., Murphy B.P., and Connolly S. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Archives of Disease in Childhood. Fetal and Neonatal Edition 93 3 (2008) F187-F191
29. Booth D., and Evans D.J. Anticonvulsants for neonates with seizures. Cochrane Database of Systematic Reviews 18 4 (2004) CD004218
30. Scher M.S., Alvin J., Gaus L., Minnigh B., and Painter M.J. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatric Neurology 28 4 (2003) 277-280